TRUP | Ticker Profile - Titan Protect

TRUP

Trupanion, Inc.

Financial Services · Insurance - Property & Casualty · NGM

$22.00

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$946M

Total market value of the company

Trailing P/E

36.76

Expensive — high growth expected

Forward P/E

5.03

Based on estimated future earnings — lower means cheaper

Rev Growth

+12.3%

Year-over-year revenue change

Profit Margin

1.7%

How much profit the company keeps from each dollar of revenue

ROE

7.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$39.50

+80% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 4 analysts covering this stock

About Trupanion, Inc.

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

https://www.trupanion.com

Country: United States Employees: 1,121 Industry: Insurance - Property & Casualty

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.000

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0055

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.206

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-12.7%

Historical annualised return based on price data

Max Drawdown

-61.6%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.49

Moves slightly more than the broader market

52W High

$57.89

62% below the year high

52W Low

$21.16

4% above the year low

Avg Volume

394,134

Average daily shares traded — higher means easier to buy and sell

Short Ratio

9.5

Days it would take all short sellers to cover — higher means more crowded

Short % Float

10.3%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.59

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

27.70

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.73

Healthy liquidity position

Quick Ratio

1.69

Like current ratio but excludes inventory — stricter test

Gross Margin

22.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

1.2%

Profit from core operations before interest and tax

Free Cash Flow

$-13,622,000

Negative — the business is spending more than it generates

Revenue (TTM)

$1.5B

Total revenue over the last 12 months

Net Income

$26M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$52.00

Target Median

$39.50

Target Low

$28.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go